These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Abeta(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer's disease. Bame KJ; Danda J; Hassall A; Tumova S J Biol Chem; 1997 Jul; 272(27):17005-11. PubMed ID: 9202014 [TBL] [Abstract][Full Text] [Related]
3. Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth. McLaurin J; Franklin T; Zhang X; Deng J; Fraser PE Eur J Biochem; 1999 Dec; 266(3):1101-10. PubMed ID: 10583407 [TBL] [Abstract][Full Text] [Related]
4. Effect of amino-acid substitutions on Alzheimer's amyloid-beta peptide-glycosaminoglycan interactions. McLaurin J; Fraser PE Eur J Biochem; 2000 Nov; 267(21):6353-61. PubMed ID: 11029577 [TBL] [Abstract][Full Text] [Related]
5. Proteoglycan-mediated inhibition of A beta proteolysis. A potential cause of senile plaque accumulation. Gupta-Bansal R; Frederickson RC; Brunden KR J Biol Chem; 1995 Aug; 270(31):18666-71. PubMed ID: 7629198 [TBL] [Abstract][Full Text] [Related]
6. Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. Implications for islet amyloid formation. Park K; Verchere CB J Biol Chem; 2001 May; 276(20):16611-6. PubMed ID: 11145957 [TBL] [Abstract][Full Text] [Related]
7. Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide. Buée L; Ding W; Anderson JP; Narindrasorasak S; Kisilevsky R; Boyle NJ; Robakis NK; Delacourte A; Greenberg B; Fillit HM Brain Res; 1993 Nov; 627(2):199-204. PubMed ID: 8298962 [TBL] [Abstract][Full Text] [Related]
8. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease. Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988 [TBL] [Abstract][Full Text] [Related]
9. Novel glycosaminoglycan precursors as anti-amyloid agents part II. Kisilevsky R; Szarek WA J Mol Neurosci; 2002; 19(1-2):45-50. PubMed ID: 12212792 [TBL] [Abstract][Full Text] [Related]
10. The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation. Castillo GM; Lukito W; Wight TN; Snow AD J Neurochem; 1999 Apr; 72(4):1681-7. PubMed ID: 10098877 [TBL] [Abstract][Full Text] [Related]
11. Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide. Buée L; Ding W; Delacourte A; Fillit H Brain Res; 1993 Jan; 601(1-2):154-63. PubMed ID: 8431762 [TBL] [Abstract][Full Text] [Related]
12. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain. Snow AD; Sekiguchi RT; Nochlin D; Kalaria RN; Kimata K Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117 [TBL] [Abstract][Full Text] [Related]
13. Amyloid beta protein precursor is possibly a heparan sulfate proteoglycan core protein. Schubert D; Schroeder R; LaCorbiere M; Saitoh T; Cole G Science; 1988 Jul; 241(4862):223-6. PubMed ID: 2968652 [TBL] [Abstract][Full Text] [Related]
14. Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability. Castillo GM; Ngo C; Cummings J; Wight TN; Snow AD J Neurochem; 1997 Dec; 69(6):2452-65. PubMed ID: 9375678 [TBL] [Abstract][Full Text] [Related]
15. Effects of sulfate ions on Alzheimer beta/A4 peptide assemblies: implications for amyloid fibril-proteoglycan interactions. Fraser PE; Nguyen JT; Chin DT; Kirschner DA J Neurochem; 1992 Oct; 59(4):1531-40. PubMed ID: 1402902 [TBL] [Abstract][Full Text] [Related]
16. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation. Castillo GM; Cummings JA; Yang W; Judge ME; Sheardown MJ; Rimvall K; Hansen JB; Snow AD Diabetes; 1998 Apr; 47(4):612-20. PubMed ID: 9568695 [TBL] [Abstract][Full Text] [Related]
17. Interaction of 70-kDa heat shock protein with glycosaminoglycans and acidic glycopolymers. Harada Y; Garenáux E; Nagatsuka T; Uzawa H; Nishida Y; Sato C; Kitajima K Biochem Biophys Res Commun; 2014 Oct; 453(2):229-34. PubMed ID: 24909693 [TBL] [Abstract][Full Text] [Related]
18. Pigment epithelium-derived factor (PEDF) binds to glycosaminoglycans: analysis of the binding site. Alberdi E; Hyde CC; Becerra SP Biochemistry; 1998 Jul; 37(30):10643-52. PubMed ID: 9692954 [TBL] [Abstract][Full Text] [Related]
19. Ca2+-mediated association of human serum amyloid P component with heparan sulfate and dermatan sulfate. Hamazaki H J Biol Chem; 1987 Feb; 262(4):1456-60. PubMed ID: 2948956 [TBL] [Abstract][Full Text] [Related]
20. Heparin-binding properties of the amyloidogenic peptides Abeta and amylin. Dependence on aggregation state and inhibition by Congo red. Watson DJ; Lander AD; Selkoe DJ J Biol Chem; 1997 Dec; 272(50):31617-24. PubMed ID: 9395501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]